Warner Chilcott Announces Earnings Release Date for Second Quarter 2013 Financial Results

Warner Chilcott Announces Earnings Release Date for Second Quarter 2013
Financial Results

DUBLIN, Ireland, July 19, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc
(Nasdaq:WCRX) today announced that it will issue a press release detailing its
second quarter 2013 financial results after the market close on Wednesday,
July 24, 2013.

Although the Company will not be hosting a quarterly conference call,
investors and other interested parties may access the press release by
visiting http://ir.wcrx.com and clicking on Press Releases.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently
focused on the women's healthcare, gastroenterology, urology and dermatology
segments of the branded pharmaceuticals market, primarily in North America.
We are a fully integrated company with internal resources dedicated to the
development, manufacture and promotion of our products. WCRX-F

CONTACT: Rochelle Fuhrmann
         Senior Vice President, Finance
         973-442-3281
         rfuhrmann@wcrx.com
        
         Kevin Crissey
         Director, Investor Relations
         973-907-7084
         Kevin.Crissey@wcrx.com

Warner Chilcott Logo
 
Press spacebar to pause and continue. Press esc to stop.